Related references
Note: Only part of the references are listed.Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape
Leisha A. Emens et al.
EUROPEAN JOURNAL OF CANCER (2017)
Nanoparticles for tumor immunotherapy
Xinlong Zang et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2017)
Surgery Versus 5% Imiquimod for Nodular and Superficial Basal Cell Carcinoma: 5-Year Results of the SINS Randomized Controlled Trial
Hywel C. Williams et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Cancer Nanomedicine: Lessons for Immuno-Oncology
Shiladitya Sengupta
TRENDS IN CANCER (2017)
Chronic stress suppresses anti-tumor TCD8+ responses and tumor regression following cancer immunotherapy in a mouse model of melanoma
Annette Sommershof et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
Sizing the optimal dimensions of a vaccine delivery system: a particulate matter
Bram Slutter et al.
EXPERT OPINION ON DRUG DELIVERY (2016)
The STEAP1262-270 peptide encapsulated into PLGA microspheres elicits strong cytotoxic T cell immunity in HLA-A*0201 transgenic miceA new approach to immunotherapy against prostate carcinoma
Valerie L. Herrmann et al.
PROSTATE (2016)
Immune cell dysfunctions in breast cancer patients detected through whole blood multi-parametric flow cytometry assay
E. Verronese et al.
ONCOIMMUNOLOGY (2016)
Co-delivery of PLGA encapsulated invariant NKT cell agonist with antigenic protein induce strong T cell-mediated antitumor immune responses
Yusuf Dolen et al.
ONCOIMMUNOLOGY (2016)
Injectable formulations of poly(lactic acid) and its copolymers in clinical use
Anjali Jain et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
PLA micro- and nano-particles
Byung Kook Lee et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Non-glycosidic compounds can stimulate both human and mouse iNKT cells
John-Paul Jukes et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
Vaccine adjuvants as potential cancer immunotherapeutics
Burcu Temizoz et al.
INTERNATIONAL IMMUNOLOGY (2016)
Design of PLGA-based depot delivery systems for biopharmaceuticals prepared by spray drying
Feng Wan et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Orchestrating immune responses: How size, shape and rigidity affect the immunogenicity of particulate vaccines
Naomi Benne et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Analysis of nanoparticle delivery to tumours
Stefan Wilhelm et al.
NATURE REVIEWS MATERIALS (2016)
Synthetic Nanoparticles for Vaccines and Immunotherapy
Darrell J. Irvine et al.
CHEMICAL REVIEWS (2015)
Cytotoxic T cell vaccination with PLGA microspheres interferes with influenza A virus replication in the lung and suppresses the infectious disease
Valerie L. Herrmann et al.
JOURNAL OF CONTROLLED RELEASE (2015)
In vivo delivery of peptides and Toll-like receptor ligands by mannose-functionalized polymeric nanoparticles induces prophylactic and therapeutic anti-tumor immune responses in a melanoma model
Joana M. Silva et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Immunopotentiator-Loaded Polymeric Microparticles as Robust Adjuvant to Improve Vaccine Efficacy
Weifeng Zhang et al.
PHARMACEUTICAL RESEARCH (2015)
Evaluation of nano spray drying as a method for drying and formulation of therapeutic peptides and proteins
Yusuf A. Haggag et al.
FRONTIERS IN PHARMACOLOGY (2015)
A Therapeutic Microparticle-Based Tumor Lysate Vaccine Reduces Spontaneous Metastases in Murine Breast Cancer
Brett P. Gross et al.
AAPS JOURNAL (2014)
Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery
Vincent Pavot et al.
NANOMEDICINE (2014)
Biomaterials for Nanoparticle Vaccine Delivery Systems
Preety Sahdev et al.
PHARMACEUTICAL RESEARCH (2014)
Eliciting cytotoxic T-lymphocyte responses from synthetic vectors containing one or two epitopes in a C57BL/6 mouse model using peptide-containing biodegradable microspheres and adjuvants
R. M. Rubsamen et al.
VACCINE (2014)
CD4 T-cell Subsets and Tumor Immunity: The Helpful and the Not-so-Helpful
Hye-Jung Kim et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Therapeutic In Situ Autovaccination against Solid Cancers with Intratumoral Poly-ICLC: Case Report, Hypothesis, and Clinical Trial
Andres M. Salazar et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Biodegradable Particles as Vaccine Delivery Systems: Size Matters
Vijaya B. Joshi et al.
AAPS JOURNAL (2013)
Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant
Annina M. Hafner et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Immune system targeting by biodegradable nanoparticles for cancer vaccines
Joana M. Silva et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Effects of Microparticle Size and Fc Density on Macrophage Phagocytosis
Patricia Pacheco et al.
PLOS ONE (2013)
Vaccine adjuvant formulations: A pharmaceutical perspective
Luis A. Brito et al.
SEMINARS IN IMMUNOLOGY (2013)
Exploiting Endocytosis for Nanomedicines
Akin Akinc et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
NKT cells as an ideal anti-tumor immunotnerapeutic
Shin-ichiro Fujii et al.
FRONTIERS IN IMMUNOLOGY (2013)
The endocytosis and intracellular fate of nanomedicines: Implication for rational design
Longfa Kou et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Induction of Potent Antigen-specific Cytotoxic T Cell Response by PLGA-nanoparticles Containing Antigen and TLR Agonist
Young-Ran Lee et al.
Immune Network (2013)
Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype
Stacey L. Demento et al.
BIOMATERIALS (2012)
PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses
Wenxue Ma et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2012)
Coencapsulation of tumor lysate and CpG-ODN in PLGA-microspheres enables successful immunotherapy of prostate carcinoma in TRAMP mice
Marc Mueller et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Targeting tumor antigens to dendritic cells using particulate carriers
Medha D. Joshi et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Potential of NOD receptor ligands as immunomodulators in particulate vaccine carriers
Christian Wischke et al.
JOURNAL OF CONTROLLED RELEASE (2012)
PLGA-based nanoparticles: An overview of biomedical applications
Fabienne Danhier et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Biodegradable PLGA-b-PEG polymeric nanoparticles: synthesis, properties, and nanomedical applications as drug delivery system
Erica Locatelli et al.
JOURNAL OF NANOPARTICLE RESEARCH (2012)
Combination of immune stimulating adjuvants with poly(lactide-co-glycolide) microspheres enhances the immune response of vaccines
Aiala Salvador et al.
VACCINE (2012)
Adjuvant effect of microencapsulated NOD ligands studied in a human phagocytic cell line
Simi Mathew et al.
JOURNAL OF APPLIED BIOMATERIALS & FUNCTIONAL MATERIALS (2012)
Cross-presentation by dendritic cells
Olivier P. Joffre et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations
Samar Hamdy et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
Enhanced Stimulation of Anti-Ovarian Cancer CD8+T Cells by Dendritic Cells Loaded with Nanoparticle Encapsulated Tumor Antigen
Douglas J. Hanlon et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2011)
Route of Administration Modulates the Induction of Dendritic Cell Vaccine-Induced Antigen-Specific T Cells in Advanced Melanoma Patients
W. Joost Lesterhuis et al.
CLINICAL CANCER RESEARCH (2011)
Current adjuvants and new perspectives in vaccine formulation
Emanuele Montomoli et al.
EXPERT REVIEW OF VACCINES (2011)
The uptake of PLGA micro or nanoparticles by macrophages provokes distinct in vitro inflammatory response
Roberto Nicolete et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
Tumor eradication by immunotherapy with biodegradable PLGA microspheres-an alternative to incomplete Freund's adjuvant
Marc Mueller et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Nano spray drying: A novel method for preparing protein nanoparticles for protein therapy
Sie Huey Lee et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
Microencapsulation of inorganic nanocrystals into PLGA microsphere vaccines enables their intracellular localization in dendritic cells by electron and fluorescence microscopy
Christopher Schliehe et al.
JOURNAL OF CONTROLLED RELEASE (2011)
CD8- Dendritic Cells and Macrophages Cross-Present Poly( D,L-lactate-co-glycolate) Acid Microsphere-Encapsulated Antigen In Vivo
Christopher Schliehe et al.
JOURNAL OF IMMUNOLOGY (2011)
TLR3-Specific Double-Stranded RNA Oligonucleotide Adjuvants Induce Dendritic Cell Cross-Presentation, CTL Responses, and Antiviral Protection
Ivett Jelinek et al.
JOURNAL OF IMMUNOLOGY (2011)
Polymer nanoparticles containing tumor lysates as antigen delivery vehicles for dendritic cell-based antitumor immunotherapy
Shashi Prasad et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2011)
Vaccine therapy with sipuleucel-T (Provenge) for prostate cancer
Eddie Thara et al.
MATURITAS (2011)
Polymer nanoparticles: Preparation techniques and size-control parameters
J. Prasad Rao et al.
PROGRESS IN POLYMER SCIENCE (2011)
Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity
Sandra Morel et al.
VACCINE (2011)
Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines
Anil Mahapatro et al.
JOURNAL OF NANOBIOTECHNOLOGY (2011)
CD4+ T-Cell Help in the Tumor Milieu Is Required for Recruitment and Cytolytic Function of CD8+ T Lymphocytes
Rinke Bos et al.
CANCER RESEARCH (2010)
Modulation of immune responses through direct activation of Toll-like receptors to T cells
G. Liu et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Biodegradable polymeric nanoparticles based drug delivery systems
Avnesh Kumari et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2010)
Synthetic therapeutic peptides: science and market
Patrick Vlieghe et al.
DRUG DISCOVERY TODAY (2010)
Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro
Luis J. Cruz et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Differential induction of inflammatory cytokines by dendritic cells treated with novel TLR-agonist and cytokine based cocktails: targeting dendritic cells in autoimmunity
Simon S. Jensen et al.
JOURNAL OF INFLAMMATION-LONDON (2010)
Immune stimulatory antigen loaded particles combined with depletion of regulatory T-cells induce potent tumor specific immunity in a mouse model of melanoma
Robin Goforth et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Specific and non-specific phagocytosis of ligand-grafted PLGA microspheres by macrophages
Nolwenn Brandhonneur et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Concomitant delivery of a CTL-restricted peptide antigen and CpG ODN by PLGA microparticles induces cellular immune response
Stefan Fischer et al.
JOURNAL OF DRUG TARGETING (2009)
AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
Arnaud M. Didierlaurent et al.
JOURNAL OF IMMUNOLOGY (2009)
Nanoparticles target distinct dendritic cell populations according to their size
Vania Manolova et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Superior induction of anti-tumor CTL immunity by extended peptide vaccines involves prolonged, DC-focused antigen presentation
Martijn S. Bijker et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells
Anja Seubert et al.
JOURNAL OF IMMUNOLOGY (2008)
Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity
Samar Hamdy et al.
VACCINE (2008)
TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses
Eva Schlosser et al.
VACCINE (2008)
A comparative study of the antigen-specific immune response induced by co-delivery of CpG ODN and antigen using fusion molecules or biodegradable microparticles
Xue-Qing Zhang et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
Dendritic-cell immunotherapy:: from ex vivo loading to in vivo targeting
Paul J. Tacken et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Poly (lactide-co-glycolide) microspheres in respirable sizes enhance an In vitro T cell response to recombinant Mycobacterium tuberculosis antigen 85B
Dongmei Lu et al.
PHARMACEUTICAL RESEARCH (2007)
Combined Toll-like receptor agonists synergistically increase production of inflammatory cytokines in human neonatal dendritic cells
Doreen Krumbiegel et al.
HUMAN IMMUNOLOGY (2007)
Biodegradable nanoparticles for cytosolic delivery of therapeutics
Jaspreet K. Vasir et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Particle formation in spray drying
Reinhard Vehring et al.
JOURNAL OF AEROSOL SCIENCE (2007)
CD4 cells can be more efficient at tumor rejection than CD8 cells
Ainhoa Perez-Diez et al.
BLOOD (2007)
Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles
Samar Hamdy et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2007)
DC-based cancer vaccines
Eli Gilboa
JOURNAL OF CLINICAL INVESTIGATION (2007)
Pathogen-mimicking nanoparticles for vaccine delivery to dendritic cells
Praveen Elamanchili et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Identification of T-cell epitopes for cancer immunotherapy
J. H. Kessler et al.
LEUKEMIA (2007)
Toll-like receptor ligands energize peptide vaccines through multiple paths
Esteban Celis
CANCER RESEARCH (2007)
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
Ying Waeckerle-Men et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Degradation behaviour of microspheres prepared by spray-drying poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers
M. Dolores Blanco et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Targeting dendritic cells with biomaterials: developing the next generation of vaccines
Sai T. Reddy et al.
TRENDS IN IMMUNOLOGY (2006)
Key parameters affecting the initial release (burst) and encapsulation efficiency of peptide-containing poly(lactide-co-glycolide) microparticles
Xiaosong Luan et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Vaccines with the MF59 adjuvant do not stimulate antibody responses against squalene
Giuseppe Del Giudice et al.
CLINICAL AND VACCINE IMMUNOLOGY (2006)
Nanomedicines and nanotoxicology: some physiological principles
M. C. Garnett et al.
OCCUPATIONAL MEDICINE-OXFORD (2006)
Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo
Tobias Warger et al.
BLOOD (2006)
NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells
Ariel Savina et al.
CELL (2006)
How porosity and size affect the drug release mechanisms from PLIGA-based microparticles
D. Klose et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Toll-dependent selection of microbial antigens for presentation by dendritic cells
JM Blander et al.
NATURE (2006)
Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma:: a randomized phase III trial of the DC study group of the DeCOG
D Schadendorf et al.
ANNALS OF ONCOLOGY (2006)
Encapsulation of proteins and peptides into biodegradable poly(D,L-lactide-co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cells
Y Waeckerle-Men et al.
VACCINE (2006)
Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency
J Kazzaz et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Nanocarriers: Promising vehicle for bioactive drugs
Manju Rawat et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2006)
CD8(+) T-cell memory in tumor immunology and immunotherapy
Christopher A. Klebanoff et al.
IMMUNOLOGICAL REVIEWS (2006)
Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles
H Shen et al.
IMMUNOLOGY (2006)
Revisiting Freund's incomplete adjuvant for vaccines in the developing world
LH Miller et al.
TRENDS IN PARASITOLOGY (2005)
Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells
G Napolitani et al.
NATURE IMMUNOLOGY (2005)
Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model
C Foged et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Design and development of polymers for gene delivery
DW Pack et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells
SR Krutzik et al.
NATURE MEDICINE (2005)
Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909
DE Speiser et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Pathways for antigen cross presentation
P Guermonprez et al.
SPRINGER SEMINARS IN IMMUNOPATHOLOGY (2005)
Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens
WL Jiang et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines
Y Waeckerle-Men et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy
Y Waeckerle-Men et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2004)
Vaccines that facilitate antigen entry into dendritic cells
A Gamvrellis et al.
IMMUNOLOGY AND CELL BIOLOGY (2004)
Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo
LJ Shen et al.
IMMUNITY (2004)
The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules
C Watts
NATURE IMMUNOLOGY (2004)
Characterization of poly(D,L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells
P Elamanchili et al.
VACCINE (2004)
In vivo uptake of an experimental microencapsulated diphtheria vaccine following sub-cutaneous immunisation
M Peyre et al.
VACCINE (2004)
Particle formation and capture during spray drying of inhalable particles
K Mosen et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2004)
Biodegradable nanoparticle mediated antigen delivery to human cord blood derived dendritic cells for induction of primary T cell responses
M Diwan et al.
JOURNAL OF DRUG TARGETING (2004)
Antigen loading of dendritic cells with whole tumor cell preparations
P Thumann et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2003)
The use of dendritic cells in cancer immunotherapy
G Schuler et al.
CURRENT OPINION IN IMMUNOLOGY (2003)
Toll-like receptor expression in murine DC subsets:: lack of TLR7 expression by CD8α+ DC correlates with unresponsiveness to imidazoquinolines
AD Edwards et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro
R Audran et al.
VACCINE (2003)
Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres
I Gutierro et al.
VACCINE (2002)
Analysis of poly(D,L-lactic-co-glycolic acid) nanosphere uptake by human dendritic cells and macrophages in vitro
MEC Lutsiak et al.
PHARMACEUTICAL RESEARCH (2002)
Characterization of the initial burst release of a model peptide from poly(D,L-lactide-co-glycolide) microspheres
J Wang et al.
JOURNAL OF CONTROLLED RELEASE (2002)
Uptake of poly(D,L-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo
KD Newman et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH (2002)
Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells
B Schuler-Thurner et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells
A Engering et al.
JOURNAL OF IMMUNOLOGY (2002)
Biodegradable microspheres containing group B Streptococcus vaccine:: Immune response in mice
SK Hunter et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2001)
Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens
N Kadowaki et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Hydrophilic poly(DL-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells
E Walter et al.
JOURNAL OF CONTROLLED RELEASE (2001)
A phase I clinical trial of a mufti-epitope polypeptide TAB9 combined with Montanide ISA 720 adjuvant in non-HIV-1 infected human volunteers
H Toledo et al.
VACCINE (2001)
Cell-associated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo
M Li et al.
JOURNAL OF IMMUNOLOGY (2001)
Parameters influencing the antigen release from spray-dried poly(DL-lactide) microparticles
B Baras et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2000)
Share Paper
